George Mason University’s (GMU) 52,000 square-foot Biomedical Research Laboratory (BRL) is one of 12 NIAID-funded regional biocontainment facilities to support infectious disease research and foster collaborations with other national and global laboratories. The BRL is fully approved and licensed for work by the CDC and USDA and is accredited by AAALAC. It is located on Mason’s SciTech campus (Manassas, VA), situated 40 miles from Washington D.C.Our innovative faculty actively engage in and value interdisciplinary collaborations. We also have an applied research support services team led by Mason’s Institute for Biohealth Innovation to work with external partners including academia, not-for-profit organizations, industry, and government studying biodefense and emerging infectious diseases.Attendees will learn about the capabilities we have to 1) generate advanced knowledge of pathogen biology and host interaction mechanisms and 2) evaluate diagnostics, therapeutics and vaccines to counter the threat of bio-terrorism and newly emerging or re-emerging infectious diseases. They will also learn about related faculty expertise and platform technologies that are being developed to support advancement of new infectious disease countermeasures.Speakers: Amy Adams, Executive Director, Institute for Biohealth Innovation, Dr. Farhang Alem, Interim Director, Regional Biocontainment Laboratory
This event has passed.
